Abstract: Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) is a type II membrane protein isolated as a human tumor-associated antigen against a human uterine adenocarcinoma cell line, SiSo. RCAS1 acts as a ligand for a putative receptor present on immune cells such as T, B, and NK cells and inhibits the growth of receptor-expressing cells, further inducing apoptotic cell death. These observations suggest a role of RCAS1 in the immune escape of tumor cells. Although a variety of cancer tissues have been screened and found to be positive for RCAS1 expression, whether RCAS1 is expressed in head and neck cancer remains unclear. This study examined whether RCAS1 is expressed in adenoid cystic carcinoma (ACC) tissues or various cell lines (HSG, AZA1, AZA3, and HSY) derived from human salivary glands and whether tumor cells that express RCAS1 induce apoptosis of its receptor-positive cells, peripheral blood lymphocytes (PBLs). RCAS1 transcripts and proteins were detected in 4 cell lines. Immunohistochemical examinations revealed that RCAS1 was slightly to moderately positive in 11 of 13 cases (84.6 %) of ACC. Confocal laser microscopy showed that PBLs stimulated with interleukin (IL) -2 undergo apoptosis by co-culturing with HSG or HSY cells. Our results of TUNEL showed that apoptotic tumor-infiltrating lymphocytes were distinctly observed around RCAS1-positive tumor cells in ACC tissues. These results suggest that RCAS1 expression might be associated with the progression of salivary gland tumors and a possible mechanism for oral cancer immune escape.

